You have 9 free searches left this month | to do more
Showing 1 - 25 of
8,393 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Adenocarcinoma of the Prostate
    • Brest, France
      CHRU Brest
    2022-01-17
    Jan 17, 2022
    U
    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2022-04-04
    Apr 4, 2022
    U
    Active, not recruiting
    • Prostate Adenocarcinoma
    • F-18 fluciclovine-PET/CT scan
    • Tucson, Arizona
      University of Arizona
    2022-03-07
    Mar 7, 2022
    S
    Active, not recruiting
    • Prostate Cancer
    • hypofractionation
    • Baltimore, Maryland
      The Johns Hopkins University School of Medicne
    2022-03-18
    Mar 18, 2022
    J
    Recruiting
    • Prostate Adenocarcinoma
    • +7 more
    • High-Dose Rate Brachytherapy
    • Stereotactic Body Radiation Therapy
    • Los Angeles, California
      University of California at Los Angeles / Jonsson Comprehensive
    2021-10-07
    Oct 7, 2021
    U
    Not yet recruiting
    • Prostate Cancer
    • Prostate Adenocarcinoma
    • TRUS biopsy
    • Tucson, Arizona
      University of Arizona
    2022-02-23
    Feb 23, 2022
    C
    Active, not recruiting
    • Adenocarcinoma of the Prostate
    • EPISPOT detection of the number of circulating cells
    • CellSearch detection of the number of circulating, functional, prostate cells
    • Nîmes Cedex 09, Gard, France
    • +4 more
    2021-08-04
    Aug 4, 2021
    O
    Active, not recruiting
    • Castration-Resistant Prostate Carcinoma
    • +6 more
    • San Francisco, California
    • +1 more
    2021-11-18
    Nov 18, 2021
    U
    Recruiting
    • Adenocarcinoma of the Prostate
    • Stereotactic Radiosurgical Boost
    • +2 more
    • Sacramento, California
      UC Davis Sacramento Cancer Center Dept of Radiation Oncology
    2021-09-24
    Sep 24, 2021
    M
    Active, not recruiting
    • Stage I Prostate Adenocarcinoma AJCC v7
    • Stage II Prostate Adenocarcinoma AJCC v7
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    2022-02-09
    Feb 9, 2022
    S
    Enrolling by invitation
    • Prostate Cancer
    • +5 more
    • 131I-PSMA-1095 Radioligand Therapy (RLT)
    • Montreal, Quebec, Canada
      Stephan Probst
    2021-09-20
    Sep 20, 2021
    N
    Terminated
    • Prostate Cancer
    • +6 more
    • NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
    • Tampa, Florida
    • +3 more
    2022-03-02
    Mar 2, 2022
    M
    Active, not recruiting
    • Metastatic Malignant Neoplasm in Lymph Node
    • +3 more
    • Antiandrogen Therapy
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    2022-03-03
    Mar 3, 2022
    U
    Active, not recruiting
    • Stage II Prostate Adenocarcinoma
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Los Angeles, California
      USC Norris Comprehensive Cancer Center
    2021-11-16
    Nov 16, 2021
    C
    Recruiting
    • Adenocarcinoma of the Prostate
    • Stereotactic Radiotherapy with Linac MRI
    • Dijon, France
      Centre Georges François Leclerc
    2021-05-27
    May 27, 2021
    S
    Active, not recruiting
    • Prostate Cancer
    • Adenocarcinoma of the Prostate
    • Brachytherapy
    • Baltimore, Maryland
      The SKCCC at Johns Hopkins
    2021-11-04
    Nov 4, 2021
    A
    Not yet recruiting
    • Prostate Adenocarcinoma
    • Immunohistochemistry of prostate biopsy
    • (no location specified)
    2021-03-30
    Mar 30, 2021
    J
    Active, not recruiting
    • Prostate Cancer
    • +3 more
    • Stereotactic Body Radiation Therapy with Integrated Boost
    • Birmingham, Alabama
      Hazelrig-Salter Radiation Oncology Center
    2022-03-25
    Mar 25, 2022
    M
    Active, not recruiting
    • Prostate Cancer
    • Bronx, New York
      Montefiore Medical Center
    2021-02-18
    Feb 18, 2021
    A
    Recruiting
    • Prostate Adenocarcinoma
    • Niraparib Pill
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    2022-03-29
    Mar 29, 2022
    S
    Not yet recruiting
    • Prostate Adenocarcinoma
    • +2 more
    • radium-223
    • Bipolar Androgen Therapy (BAT)
    • Baltimore, Maryland
    • +1 more
    2022-03-02
    Mar 2, 2022
    B
    Recruiting
    • Advanced Prostate Adenocarcinoma
    • Leuprolide Acetate 3.75 MG/ML
    • Nagpur, Maharashtra, India
    • +1 more
    2022-01-23
    Jan 23, 2022
    J
    Active, not recruiting
    • Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    2021-12-07
    Dec 7, 2021
    A
    Not yet recruiting
    • Prostate Adenocarcinoma
    • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
    • Haifa, Israel
      RAMBAM Health Care Campus
    2022-02-16
    Feb 16, 2022
    U
    Active, not recruiting
    • Adenocarcinoma of the Prostate
    • Dose Escalated IMRT
    • Toronto, Ontario, Canada
      University Health Network, Princess Margaret Hospital
    2021-10-01
    Oct 1, 2021